Upregulated expression of PTTG1 is associated with progression of pancreatic cancer
Open Access
- 1 February 2024
- journal article
- research article
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 15 (1) , 435-457
Abstract
Background: Pancreatic cancer (PC) is an aggressive disease with a very poor prognosis. The insidious onset, rapid progression, and resistance to conventional therapies mark the imperious need for novel biomarkers and therapeutic targets. The pituitary tumor transforming gene 1 (PTTG1), implicated in tumorigenesis and cellular transformation, has been studied in various cancers, however, its role and mechanisms in PC remain to be elucidated for better understanding the disease pathology and in enhancing patient management strategies. Methods: The present study examined the PTTG1 messenger RNA (mRNA) expression levels and clinical significance through meta-analysis based on The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Immunohistochemistry (IHC) was used to measure PTTG1 protein levels in PC and adjacent non-cancerous tissues. A correlation was observed between PTTG1 expression and some clinical characteristics based on the TCGA and IHC data. Univariate and multivariate Cox regressions were used to identify independent prognostic factors. Kaplan-Meier (KM) survival analysis was performed. The co-expressed genes of PTTG1 were determined by integrating online tools, and the enrichment analyses were performed to determine PTTG1-related pathways and hub co-expressed genes. Results: PTTG1 was highly expressed in PC tissues based on the TCGA, GEO, and IHC data. The combined standard mean difference (SMD) values of PTTG1 expression based on TCGA and GEO databases was 1.02 [95% confidence interval (CI): 0.74–1.30]. The area under the curve (AUC) based on the summary receiver operating characteristic (sROC) curve was 0.93 (95% CI: 0.90–0.95). PTTG1 overexpression was remarkably correlated with an inferior overall survival (OS). A total of 367 genes were identified as co-expressed genes of PTTG1 in PC and were mainly involved in the cell cycle pathway. The four identified core genes were CDK1, CCNA2, CDC20, and MAD2L1. Conclusions: The upregulated expression of PTTG1 plays an essential role in PC’s progression as a biomarker.Keywords
This publication has 71 references indexed in Scilit:
- Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and TumorigenesisCancer Research, 2014
- Molecular Functions of Thyroid Hormones and Their Clinical Significance in Liver-Related DiseasesBioMed Research International, 2013
- Clinical Significance of Pituitary Tumor Transforming Gene 1 and Transgelin-2 in Pancreatic CancerInternational Journal of Immunopathology and Pharmacology, 2013
- The cell cycle and cancerThe Journal of Pathology, 2011
- Inhibition of pituitary tumor‐transforming gene‐1 in thyroid cancer cells by drugs that decrease specificity proteinsMolecular Carcinogenesis, 2011
- The anaphase-promoting complex/cyclosome (APC/C): cell-cycle-dependent and -independent functionsBiochemical Society Transactions, 2010
- The pituitary tumor transforming gene 1 (PTTG-1): An immunological target for multiple myelomaJournal of Translational Medicine, 2008
- Pituitary Tumor-Transforming Gene: Physiology and Implications for TumorigenesisEndocrine Reviews, 2007
- Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patientsOncology Reports, 2006
- The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancerJournal of Carcinogenesis, 2006